Articles seleccionats (2009)
Bestard O, Cruzado JM, Grinyó JM. Inhibitors of the mammalian target of rapamycin and transplant tolerance. Transplantation 2009; 87 (Suppl. 8): S27-S29
Caldés A, Colom H, Armendariz Y, Garrido MJ, Troconiz IF, Gil-Vernet S, Lloberas N, Pou L, Peraire C, Grinyó JM. Population pharmacokinetics of ganciclovir after intravenous ganciclovir and oral valganciclovir administration in solid organ transplant pacients infected with cytomegalovirus. Antimicrobial Agents & Chemotherapy 2009; 53 (11): 4816-4824
Cruzado JM, Rodríguez de Córdoba S, Melilli E, Bestard O, Rama I, Sánchez-Corral P, López-Trascasa M, Navarro I, Torras J, Gomà M, Grinyó JM. Successful renal transplantation in a patient with atypical hemolytic uremic syndrome carrying mutations in both factor I and MCP. American Journal of Transplantation 2009; 9:1477-1483
Grinyó JM, Cruzado JM. Mycophenolate mofetil and calcineurin-inhibitor reduction: recent progress. American Journal of Transplantation 2009; 9 (11):2447-2452.
Torras J, Herrero-Fresneda I, Gulías O, Flaquer M, Vidal A, Cruzado JM, Lloberas N, Franquesa M, Grinyó JM. Rapamycin has dual opposing effects on proteinuric experimental nephropaties: is it a matter of podocyte damage? Nephrology, Dialysis & Transplantation 2009; 24 (12): 3632-3640.
Immunosupressió